The company, Biotricity — which focuses on lowering healthcare costs by using technology to manage chronic diseases — was hit with a 25 percent tariff on Chinese-imported parts that went into effect Sept. 1.
Many of the small mechanical parts Biotricity uses in its devices are only made in China, the company told Fox Business.
One of Biotricity’s suppliers told Fox Business it plans to raise the price of its products because it can’t absorb the costs of the tariffs.
The Medical Imaging and Technology Alliance estimated the new tariffs will cost the U.S. medical technology industry about $138 million.
More articles on supply chain:
Judge approves reopening of Sterigenics, whose February closure caused device shortages
New ‘supercooling’ storage technique may increase number of liver transplants
Sales stall for medical device designed as opioid alternative
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
